Abstract:Background Calcium-sensing receptor (CaSR) is expressed by parathyroid cells and thyroid C-cells (from which medullary thyroid carcinoma [MTC] is derived). A molecular imaging agent localizing to the CaSR could improve the detection of parathyroids and MTC preoperatively or intraoperatively. We synthesized a novel compound containing a fluorine residue for potential future labeling and demonstrated that the compound inhibited CaSR function in vitro. Methods We synthesized compound M, a derivative of a known calcilytic compound, Calhex-231. Human embryonic kidney cells transfected with green-fluorescent protein-tagged CaSR or control vector were preincubated with compound M before the addition of calcium. Immunoblotting for total mitogen-activated protein kinase (MAPK: ERK1/2), activated MAPK (phosphorylated ERK1/2), and glyceraldehyde 3-phosphate dehydrogenase was performed. Results Synthesis of compound M was confirmed by mass spectrometry. Inhibition of the MAPK signaling pathway by compound M was demonstrated in a dose-dependent manner by a decrease in phosphorylated ERK1/2 with no change in total ERK1/2 levels. Compound M inhibited MAPK signaling slightly better than the parent compound. Conclusion We have developed a novel molecule which demonstrates functional inhibition of CaSR and has a favorable structure for labeling. This compound appears to be appropriate for further development as a molecular imaging tool to enhance the surgical treatment of parathyroid disease and MTC. Calcium-sensing receptor (CaSR) is expressed by parathyroid cells and thyroid C-cells (from which medullary thyroid carcinoma [MTC] is derived). A molecular imaging agent localizing to the CaSR could improve the detection of parathyroids and MTC preoperatively or intraoperatively. We synthesized a novel compound containing a fluorine residue for potential future labeling and demonstrated that the compound inhibited CaSR function in vitro. We synthesized compound M, a derivative of a known calcilytic compound, Calhex-231. Human embryonic kidney cells transfected with green-fluorescent protein-tagged CaSR or control vector were preincubated with compound M before the addition of calcium. Immunoblotting for total mitogen-activated protein kinase (MAPK: ERK1/2), activated MAPK (phosphorylated ERK1/2), and glyceraldehyde 3-phosphate dehydrogenase was performed. Synthesis of compound M was confirmed by mass spectrometry. Inhibition of the MAPK signaling pathway by compound M was demonstrated in a dose-dependent manner by a decrease in phosphorylated ERK1/2 with no change in total ERK1/2 levels. Compound M inhibited MAPK signaling slightly better than the parent compound. We have developed a novel molecule which demonstrates functional inhibition of CaSR and has a favorable structure for labeling. This compound appears to be appropriate for further development as a molecular imaging tool to enhance the surgical treatment of parathyroid disease and MTC.

Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor

Purification and characterization of calcitonin receptors in rat kidney membranes by covalent cross-linking techniques

[The Cloning and Expression of Salmon Calcitonin Gene in Escherichia Coli].

Peptide Engineering Approach to Introduce an Improved Calcitonin Mutant

A recombinant calcitonin receptor independently stimulates 3',5'-cyclic adenosine monophosphate and Ca2+/inositol phosphate signaling pathways

Cell Active and Functionally-Relevant Small-Molecule Agonists of Calcitonin Receptor.

Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe

Hetero Interaction with an Amino Acid Globally Enhances Cooperative Activation of Casr in Response to Extracellular Signaling

Homology Modeling Identifies C-Terminal Residues That Contribute to the Ca2+ Sensitivity of A Bkca Channel

Growth-incompetent Monomers of Human Calcitonin Lead to a Noncanonical Direct Relationship Between Peptide Concentration and Aggregation Lag Time

Direct Determination of Multiple Ligand Interactions with the Extracellular Domain of the Calcium-sensing Receptor*

Tuning the double lipidation of salmon calcitonin to introduce a pore-like membrane translocation mechanism

Spatial Approximations Between Residues 6 and 12 in the Amino-Terminal Region of Glucagon-Like Peptide 1 and Its Receptor A Region Critical for Biological Activity

Development of a Calcium-Sensing Receptor Molecular Imaging Agent

Production of Bioactive Salmon Calcitonin from the Nonendocrine Cell Lines Cos-7 and Cho

Spectroscopic Characterization of A High-Affinity Calmodulin-Target Peptide Hybrid Molecule

Unraveling the underlying mechanisms of reduced amyloidogenic properties in human calcitonin via double mutations

Critical Extracellular Ca2+ Dependence of the Binding Between PTH1R and a G-Protein Peptide Revealed by MD Simulations.

Target recognition by calmodulin: dissecting the kinetics and affinity of interaction using short peptide sequences

Effects of pH values on the conformation of salmon calcitonin in aqueous solution

Reversed-phase High-Performance Liquid Chromatography of Radioiodinated Salmon Calcitonins